Finance

Lists
Why is AURA up 3,24%?
Dive Deeper
AURA:NASDAQ
Aura Biosciences Inc
6,37 $
+3,24%
(+0,20) 1D
15 հոկ, 10:06:59 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AURA...
Open
6,23 $
High
6,42 $
Low
6,08 $
Mkt. cap
660,61 մլն
Avg. vol.
961,57 հզր
Volume
63,95 հզր
52-wk high
9,54 $
52-wk low
4,73 $
EPS
-1,76 $
Beta
0,41
Shares outstanding
103,70 մլն
No. of employees
113
Open
6,23 $
High
6,42 $
Low
6,08 $
Mkt. cap
660,61 մլն
Avg. vol.
961,57 հզր
Volume
63,95 հզր
52-wk high
9,54 $
52-wk low
4,73 $
EPS
-1,76 $
Beta
0,41
Shares outstanding
103,70 մլն
No. of employees
113
News stories
From web sources and news partners
About Aura Biosciences Inc
CEO-
Employees113
Founded2009
HeadquartersԲոստոն, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websiteaurabiosciences.com
Analyst ratings
Based on 2 analysts giving stock ratings to AURA in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for AURA in the last 3 months.
Highest
Current 6,37 $
23,00 $ (+261,06%)
Average
20,50 $ (+221,82%)
Lowest
18,00 $ (+182,57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Oliver McCammon
LifeSci Capital
Buy
Maintained
23,00 $
+261,1%
08/12/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
18,00 $
+182,6%
08/12/2026
Andrew Berens
Leerink Partners
Buy
Reiterated
-
-
06/02/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
05/11/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
15,00 $
+135,5%
04/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22,18 մլն
21,90 մլն
27,96 մլն
30,75 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,73 մլն
5,34 մլն
6,91 մլն
17,32 մլն
Operating expense
27,91 մլն
27,24 մլն
34,87 մլն
48,07 մլն
Total operating expenses
27,91 մլն
27,24 մլն
34,87 մլն
48,07 մլն
Operating income
-27,91 մլն
-27,24 մլն
-34,87 մլն
-48,07 մլն
Other non operating income
-13,00 հզր
149,00 հզր
2,00 հզր
154,00 հզր
EBT including unusual items
-26,10 մլն
-25,54 մլն
-33,67 մլն
-45,61 մլն
EBT excluding unusual items
-26,10 մլն
-25,54 մլն
-33,67 մլն
-45,61 մլն
Income tax expense
26,00 հզր
15,00 հզր
11,00 հզր
29,00 հզր
Effective tax rate
-0,10%
-0,06%
-0,03%
-0,06%
Other operating expenses
-
-
-
-
Net income
-26,13 մլն
-25,56 մլն
-33,68 մլն
-45,64 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1,82 մլն
1,54 մլն
1,19 մլն
2,31 մլն
Interest expense
-
-
-
-
Net interest expenses
1,82 մլն
1,54 մլն
1,19 մլն
2,31 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-27,63 մլն
-26,96 մլն
-34,59 մլն
-47,81 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps